Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study

Aims/hypothesisSmall cohort studies raise the hypothesis that corneal nerve abnormalities (including corneal nerve fibre length [CNFL]) are valid non-invasive imaging endpoints for diabetic sensorimotor polyneuropathy (DSP). We aimed to establish concurrent validity and diagnostic thresholds in a large cohort of participants with and without DSP.MethodsNine hundred and ninety-eight participants from five centres (516 with type 1 diabetes and 482 with type 2 diabetes) underwent CNFL quantification and clinical and electrophysiological examination. AUC and diagnostic thresholds were derived and validated in randomly selected samples using receiver operating characteristic analysis. Sensitivity analyses included latent class models to address the issue of imperfect reference standard.ResultsType 1 and type 2 diabetes subcohorts had mean age of 42 ± 19 and 62 ± 10 years, diabetes duration 21 ± 15 and 12 ± 9 years and DSP prevalence of 31% and 53%, respectively. Derivation AUC for CNFL was 0.77 in type 1 diabetes (p < 0.001) and 0.68 in type 2 diabetes (p < 0.001) and was approximately reproduced in validation sets. The optimal threshold for automated CNFL was 12.5 mm/mm2 in type 1 diabetes and 12.3 mm/mm2 in type 2 diabetes. In the total cohort, a lower threshold value below 8.6 mm/mm2 to rule in DSP and an upper value of 15.3 mm/mm2 to rule out DSP were associated with 88% specificity and 88% sensitivity.Conclusions/interpretationWe established the diagnostic validity and common diagnostic thresholds for CNFL in type 1 and type 2 diabetes. Further research must determine to what extent CNFL can be deployed in clinical practice and in clinical trials assessing the efficacy of disease-modifying therapies for DSP.

[1]  L. E. Lovblom,et al.  Higher magnification lenses versus conventional lenses for evaluation of diabetic neuropathy by corneal in vivo confocal microscopy. , 2012, Diabetes research and clinical practice.

[2]  A. Nettel-Aguirre,et al.  The Reliability and Reproducibility of Corneal Confocal Microscopy in Children. , 2015, Investigative ophthalmology & visual science.

[3]  Elise M. Halpern,et al.  Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy , 2015, PloS one.

[4]  V. Bril.  Role of Electrophysiological Studies in Diabetic Neuropathy , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[5]  David Moher,et al.  STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies , 2015, BMJ : British Medical Journal.

[6]  Nathan Efron,et al.  Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy , 2007, Diabetes.

[7]  The impact of common variation in the definition of diabetic sensorimotor polyneuropathy on the validity of corneal in vivo confocal microscopy in patients with type 1 diabetes: a brief report. , 2013, Journal of diabetes and its complications.

[8]  G. Reid,et al.  A comparison of two methods for measuring thermal thresholds in diabetic neuropathy. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[9]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[10]  M. Nathan,et al.  Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial , 1995, Annals of neurology.

[11]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[12]  Mohammad A. Dabbah,et al.  Small Nerve Fiber Quantification in the Diagnosis of Diabetic Sensorimotor Polyneuropathy: Comparing Corneal Confocal Microscopy With Intraepidermal Nerve Fiber Density , 2015, Diabetes Care.

[13]  Gary Longton,et al.  Accommodating Covariates in ROC Analysis. , 2009, The Stata journal.

[14]  Nathan Efron,et al.  Corneal Confocal Microscopy , 2010, Diabetes Care.

[15]  Nathan Efron,et al.  Normative Values for Corneal Nerve Morphology Assessed Using Corneal Confocal Microscopy: A Multinational Normative Data Set , 2015, Diabetes Care.

[16]  Agreement between automated and manual quantification of corneal nerve fiber length: Implications for diabetic neuropathy research. , 2017, Journal of diabetes and its complications.

[17]  Minshan Jiang,et al.  Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysis , 2015, British Journal of Ophthalmology.

[18]  Steven Orlov,et al.  Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes , 2012, Diabetes Care.

[19]  L. E. Lovblom,et al.  Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients? , 2014, Diabetes Care.

[20]  Mohammad A. Dabbah,et al.  An Automatic Tool for Quantification of Nerve Fibers in Corneal Confocal Microscopy Images , 2017, IEEE Transactions on Biomedical Engineering.

[21]  P. Bossuyt,et al.  Evaluation of diagnostic tests when there is no gold standard. A review of methods. , 2007, Health technology assessment.

[22]  Mitra Tavakoli,et al.  Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies. , 2011, Journal of visualized experiments : JoVE.

[23]  N. Pritchard,et al.  Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study , 2012, Clinical & experimental optometry.

[24]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[25]  Roni M. Shtein,et al.  Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus. , 2014, Journal of diabetes and its complications.

[26]  G. Gronseth,et al.  Distal symmetric polyneuropathy: A definition for clinical research , 2005, Neurology.

[27]  R. Freeman,et al.  Diabetic Neuropathy: A Position Statement by the American Diabetes Association , 2016, Diabetes Care.